Bristol-Myers Squibb Company (BRM.F) Stock Price, News & Chart

	BRM.F	ABBV	BIIB	GILD	LLY	CUP.F
Market cap	116.51B	521.00B	37.61B	216.41B	1.26T	65.86B
P/E (TTM)	14.7	50.7	110.2	—	46.0	24.0
Forward P/E	—	18.2	15.6	17.3	28.3	0.3
Price/book	5.6	-113.7	2.0	16.6	31.4	5.6
Dividend yield	4.03%	2.35%	—	1.88%	0.49%	1.93%
1-year change	+39.42%	+34.60%	+62.35%	+41.39%	+51.26%	−1.62%
Today	+1.55%	+3.09%	+2.22%	+4.19%	+0.61%	+4.33%

Market cap

116.51B

521.00B

37.61B

216.41B

1.26T

65.86B

P/E (TTM)

14.7

50.7

110.2

—

46.0

24.0

Forward P/E

—

18.2

15.6

17.3

28.3

0.3

Price/book

5.6

-113.7

2.0

16.6

31.4

5.6

Dividend yield

4.03%

2.35%

—

1.88%

0.49%

1.93%

1-year change

+39.42%

+34.60%

+62.35%

+41.39%

+51.26%

−1.62%

Today

+1.55%

+3.09%

+2.22%

+4.19%

+0.61%

+4.33%

Company	Mkt cap	Price	Today
AbbVie Inc.ABBV · Drug Manufacturers - General	521.00B	294.83	+3.09%
Biogen Inc.BIIB · Drug Manufacturers - General	37.61B	254.46	+2.22%
Gilead Sciences, Inc.GILD · Drug Manufacturers - General Odds	216.41B	174.48	+4.19%
Eli Lilly and CompanyLLY · Drug Manufacturers - General Odds	1.26T	1,417.99	+0.61%
Chugai Pharmaceutical Co., Ltd.CUP.F · Drug Manufacturers - General	65.86B	40.02	+4.33%
Amgen Inc.AMGN · Drug Manufacturers - General	258.68B	478.48	+3.73%

Company	Mkt cap	Price	Today
SanofiSNY · Paris, France	113.74B	47.47	+4.72%
GSK plcGSK · London, United Kingdom	102.53B	51.15	+5.03%
CSPC Pharmaceutical Group Limited1093.HK · Shijiazhuang, China	97.86B	8.580	+2.63%
Marksans Pharma LimitedMARKSANS.BO · Mumbai, India	142.25B	313.65	+4.15%
Novo Nordisk A/SNOV.DE · Bagsvaerd, Denmark	163.08B	36.99	−2.53%
Gilead Sciences, Inc.1GILD.MI · Foster City, CA	159.56B	128.64	−2.22%
Zhangzhou Pientzehuang Pharmaceutical Co., Ltd.600436.SS · Zhangzhou, China	81.65B	135.33	+2.39%
Sanofi India LimitedSANOFI.BO · Mumbai, India	77.83B	3,379.40	+0.11%

Company	Mkt cap	Price	Today
Metropolis Healthcare LimitedMETROPOLIS.BO · Diagnostics & Research	118.56B	571.30	−1.85%
HLB bioStep Co.,Ltd.278650.KQ · Biotechnology	91.19B	5,300.00	+4.33%
Medtronic plc2M6.F · Medical Devices	118.88B	92.94	−0.79%
Mochida Pharmaceutical Co., Ltd.4534.T · Drug Manufacturers - Specialty & Generic	119.24B	3,395.00	+3.66%
Stryker CorporationSYK.F · Medical Devices	114.32B	300.30	−0.46%
Akums Drugs and Pharmaceuticals LimitedAKUMS.BO · Drug Manufacturers - Specialty & Generic	114.04B	744.85	−0.76%
SAMSUNG PHARM. Co., LTD.001360.KS · Drug Manufacturers - Specialty & Generic	118.87B	1,263.00	+0.08%
Coloplast A/S0QBO.IL · Medical Instruments & Supplies	119.73B	517.80	−0.02%

Company	Mkt cap	Price	Today
Clearway Energy, Inc.CWEN · Princeton, NJ	8.81B	35.71	+3.72%
Essential Properties Realty Trust, Inc.EPRT · Princeton, NJ	6.10B	28.12	+2.52%
Miami International Holdings, Inc.MIAX · Princeton, NJ	3.50B	34.97	+3.28%
UroGen Pharma Ltd.URGN · Princeton, NJ	1.40B	28.74	−16.45%
Kardigan, Inc.KARD · Princeton, NJ	1.45B	15.56	+8.66%
Integra LifeSciences Holdings CorporationIART · Princeton, NJ	1.15B	14.82	+8.73%
Princeton Bancorp, Inc.BPRN · Princeton, NJ	303.29M	44.51	+1.48%
PDS Biotechnology CorporationPDSB · Princeton, NJ	136.51M	1.3000	−7.80%

Company	Mkt cap	Price	Today
Pfizer Inc.PFE.NE · government · life sciences · healthcare	237.39B	13.65	+2.55%
Organon & Co.OGN · government · healthcare · retail	3.63B	13.83	−0.14%
BioMarin Pharmaceutical Inc.BMRN · government · life sciences · healthcare	11.06B	57.13	+2.64%
Revvity, Inc.RVTY · government · life sciences · healthcare	17.79B	159.43	−2.48%
OraSure Technologies, Inc.OSUR · government · life sciences · healthcare	256.56M	3.7200	+5.38%
Bio-Rad Laboratories, Inc.BIO · government · life sciences · healthcare	10.16B	379.99	+1.35%
Amneal Pharmaceuticals, Inc.AMRX · government · life sciences · healthcare	6.95B	19.95	−1.29%
ISP Global Limited8487.HK · government · healthcare · retail	75.36M	0.072	0.00%

Company	Mkt cap	Price	Today
Bristol-Myers Squibb CompanyBRM.DE · Correlation 0.76	117.90B	57.68	+2.85%
Bristol-Myers Squibb CompanyBMYS.VI · Correlation 0.74	117.35B	57.41	+2.44%
GSK plcGSK · Correlation 0.38	102.53B	51.15	+5.03%
Amgen Inc.AMGN · Correlation 0.38	258.68B	478.48	+3.73%
SanofiSNY · Correlation 0.34	113.74B	47.47	+4.72%
Gilead Sciences, Inc.1GILD.MI · Correlation 0.34	159.56B	128.64	−2.22%
Pfizer Inc.PFE · Correlation 0.34 Odds	175.50B	30.79	+2.63%
Gilead Sciences, Inc.GILD · Correlation 0.33 Odds	216.41B	174.48	+4.19%

Company	Mkt cap	Price	Today
BRISTOL-MYERS SQUIBB CO.BRM.DE	117.90B	57.68	+2.85%
AMERICAN EXPRESS CO.AEC1.F	199.22B	297.10	+0.75%
BRISTOL-MYERS SQUIBB COBMYS.VI	117.35B	57.41	+2.44%
Ping An Insurance(Grp)Co.ChinaRPZX.F	110.09B	6.08	+1.76%
RIO TINTO PLCRIOA.F	123.29B	75.80	+1.07%

MarketScreener·15h agoNegative

Spain's Rovi Closes Purchase of Bristol-Myers Squibb's Pharma Manufacturing Plant in Arizona, US

Laboratorios Farmaceuticos Rovi completed the acquisition of a pharmaceutical manufacturing plant in Arizona, US, and related assets and liabilities from biopharmaceutical group Bristol-Myers... Spain's Rovi Closes Purchase of…

BMY AZN PFE

MarketBeat·22h agoPositive

Bristol Myers Squibb Company $BMY Stock Holdings Raised by Rakuten Investment Management Inc.

MarketBeat Bristol Myers Squibb Company $BMY Stock Holdings Raised by Rakuten Investment Management Inc. - Rakuten Investment Management increased its Bristol Myers Squibb stake by 9.6% in the third quarter

BMY ABBV PFE

openPR.com·1d ago

Gastric Cancer Market to Expand Rapidly by 2035 Amid Increasing Investments and Innovation | AstraZeneca, Daiichi Sankyo, Bristol-Myers Squibb, Amgen, Jazz Pharma, BeiGene, Zymeworks, ALX Oncology

Gastric Cancer Market to Expand Rapidly by 2035 Amid Increasing openPR.com Gastric Cancer Market to Expand Rapidly by 2035 Amid Increasing Investments and Innovation | AstraZeneca, Daiichi Sankyo, Bristol-Myers Squibb, Amgen, Jazz Pharma,…

PFS AZN

Markets Daily·1d agoPositive

Bausch Health Cos (NYSE:BHC) & Bristol Myers Squibb (NYSE:BMY) Head-To-Head Comparison

Posted by Sarita Garza on Nov 4th, 2026 Bristol Myers Squibb (NYSE:BMY – Get Free Report) and Bausch Health Cos (NYSE:BHC – Get Free Report) are both healthcare companies, but which is the better business? We will compare the two companies…

BMY PFE MCK JNJ

@PRNewswire·21h agoPositive

Bristol Myers Squibb Canada Partners with TANK Worldwide and Ogilvy Health to Turn Autumn Leaves into a Guide for Spotting the Warning Signs of Melanoma

Nov 04, 2026, 09:27 ET As summer gives way to fall and Canadians trade shorts and T-shirts for layers, "What Summer Leaves Behind" offers a timely reminder that sun safety shouldn't end with summer and that changes in the skin are worth…

ROG

openPR.com·1d ago

Cutaneous Lupus Erythematosus Pipeline Analysis 2026: Phase III and Phase II Assets, MOA Breakdown, and ROA Trends | Biogen, Horizon Therapeutics, Bristol-Myers Squibb, AstraZeneca, Sanofi, Amgen

Albany New York November 03 2026 As per DelveInsight s assessment globally Cutaneous Lupus Erythematosus pipeline constitutes 8 key companies continuously working towards developing 10 Cutaneous Lupus Erythematosus treatment therapies…

BIIB

Trefis·1d agoNegative

What Could Derail Bristol Myers Squibb Stock?

Bristol Myers Squibb (BMY) stock returned 42.9% over the past year, compared to 11.5% for the S&P 500. If you own the stock, you want to know what could take some of that gain back, and management has already pointed to pressure on its…

BMY PFE LLY

The Motley Fool·2d ago

AbbVie vs. Bristol Myers Squibb: Which Healthcare Stock Is a Better Buy for 2027?

AbbVie boasts faster revenue growth and stronger cash generation, while Bristol Myers trades at half the valuation multiple, a classic growth-versus-value showdown. Is your portfolio ready for the shifting landscape of modern medicine?…

ABBV BMY PFE LLY

www.bms.com·2d agoPositive

Bristol Myers Squibb plans to launch Cobenfy (xanomeline and trospium chloride) in the UK at the US price, a first for the company

Science Firsthand: Making the leap to intentionally designed degraders How we orchestrate clinical trials to deliver hope for patients Building a more resilient energy future to support patients Bringing life-saving medicines to more…

BMY JNJ AZN

TIKR.com·Oct 23Positive

Tempus AI Gains 6% as Bristol Myers Squibb Licenses Oncology Data

[IMAGE CREDIT: Robert Kneschke via Canva] Tempus AI (TEM) is up 6% today after Bristol Myers Squibb (BMY) signed a multi-year deal to license Tempus’s oncology data through 2031. Tempus says BMS now “becomes one of Tempus’s largest…

TEM BMY MEDS

Days on the list

30 d

1 yr

Best

Trending

—

Install

Bristol-Myers Squibb Company

Key statistics

Against its peers

Latest news